Silencing the extra chromosome 21 in Down syndrome cells

2 November 2021

Silencing the extra chromosome 21 in Down syndrome cells

Down syndrome (DS), caused by the complete or partial triplication of chromosome 21, presents a great challenge for research, medical care and development of therapies in […]
17 May 2021

Down syndrome: a molecule that targets cognitive impairments enters the decisive phase of clinical trials

Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]